|
|
Post by peppy on Jul 22, 2016 11:46:25 GMT -5
Compare the 5y chart of Dexcom with MNKD. +470% vs -70 %. Well, that management did a great job for shareholders. Dexcom revenues have grown. shown quarterly 2016/2015 and 2011/2012. The company operating at a loss. The number of shares have increased. Hopefully revenues will help MNKD.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 22, 2016 11:49:17 GMT -5
Compare the 5y chart of Dexcom with MNKD. +470% vs -70 %. Well, that management did a great job for shareholders. Dexcom revenues have grown. shown quarterly 2016/2015 and 2011/2012. The company operating at a loss. The number of shares have increased. Hopefully revenues will help MNKD.
And how much cash in hand for the runway at dexcom? |
|
|
|
Post by peppy on Jul 22, 2016 11:52:00 GMT -5
And how much cash in hand for the runway at dexcom? Look it up oh wise seekerooo. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 22, 2016 11:59:25 GMT -5
And how much cash in hand for the runway at dexcom? Look it up oh wise seekerooo. i looked for a minute but no interest in knowing. point is s/p increase was also partially based on that |
|
|
|
Post by peppy on Jul 22, 2016 12:03:52 GMT -5
|
|
|
|
Post by sportsrancho on Jul 23, 2016 16:07:18 GMT -5
|
|
|
|
Post by agedhippie on Jul 23, 2016 17:12:10 GMT -5
The approval was for the use of a G5 to dose insulin. There are already pumps that will suspend the basal if they thinks you are going low, but they were not allowed to dose if they thought you were going high. CGMs lag real time levels by around 20 minutes so to fix that they have predictive algorithms. These work out where you probably are from the historic data. It's why for the first couple of days they can be off while they settle down and why you have to do fingersticks every so often so they can check that their model has you at the same place that you actually are. There are various tricks you can do to make that all happen faster but you need other diabetics to tell you those because Dexcom won't.  Last year Dexcom released their 505 firmware update and that finally got the accuracy to the same as a meter. The FDA approval now makes the G5 and meters equivalent and so permits dosing which clears the way for the artificial pancreas. The G4 uses the same firmware and sensors and has the same accuracy, but Dexcom only submitted the G5 for approval. There are pumps that already incorporate the G4 but the artificial pancreas devices will use the G5 as it has Bluetooth. I always dosed off a CGM when I am using one except when I feel it is wrong, then I use a meter to verify. |
|
|
|
Post by trondisc on Jul 24, 2016 2:54:03 GMT -5
The approval was for the use of a G5 to dose insulin. There are already pumps that will suspend the basal if they thinks you are going low, but they were not allowed to dose if they thought you were going high. CGMs lag real time levels by around 20 minutes so to fix that they have predictive algorithms. These work out where you probably are from the historic data. It's why for the first couple of days they can be off while they settle down and why you have to do fingersticks every so often so they can check that their model has you at the same place that you actually are. There are various tricks you can do to make that all happen faster but you need other diabetics to tell you those because Dexcom won't. Last year Dexcom released their 505 firmware update and that finally got the accuracy to the same as a meter. The FDA approval now makes the G5 and meters equivalent and so permits dosing which clears the way for the artificial pancreas. The G4 uses the same firmware and sensors and has the same accuracy, but Dexcom only submitted the G5 for approval. There are pumps that already incorporate the G4 but the artificial pancreas devices will use the G5 as it has Bluetooth. I always dosed off a CGM when I am using one except when I feel it is wrong, then I use a meter to verify. Never knew "...so to fix that they have predictive algorithms." That's friggin' awesome. Thanks for dropping some knowledge. On a pissed off unrelated sidenote: 12 days until my 1-year anniversary bagholder status first started back in August 5th of 2015. Dear Pfeffer, Castagna & the BOD: sell the company IF it means Technosphere will survive and thrive later. Letting this technology disappear from modern medicine would be a damn shameful disgrace. |
|
|
|
Post by patten1962 on Jul 24, 2016 7:03:51 GMT -5
The approval was for the use of a G5 to dose insulin. There are already pumps that will suspend the basal if they thinks you are going low, but they were not allowed to dose if they thought you were going high. CGMs lag real time levels by around 20 minutes so to fix that they have predictive algorithms. These work out where you probably are from the historic data. It's why for the first couple of days they can be off while they settle down and why you have to do fingersticks every so often so they can check that their model has you at the same place that you actually are. There are various tricks you can do to make that all happen faster but you need other diabetics to tell you those because Dexcom won't. Last year Dexcom released their 505 firmware update and that finally got the accuracy to the same as a meter. The FDA approval now makes the G5 and meters equivalent and so permits dosing which clears the way for the artificial pancreas. The G4 uses the same firmware and sensors and has the same accuracy, but Dexcom only submitted the G5 for approval. There are pumps that already incorporate the G4 but the artificial pancreas devices will use the G5 as it has Bluetooth. I always dosed off a CGM when I am using one except when I feel it is wrong, then I use a meter to verify. Never knew "...so to fix that they have predictive algorithms." That's friggin' awesome. Thanks for dropping some knowledge. On a pissed off unrelated sidenote: 12 days until my 1-year anniversary bagholder status first started back in August 5th of 2015. Dear Pfeffer, Castagna & the BOD: sell the company IF it means Technosphere will survive and thrive later. Letting this technology disappear from modern medicine would be a damn shameful disgrace. Sales team has not been on the street a month yet! This needs a few months to get rolling. I think Mannkind is doing what it needs to do. Imho, no need to sell the Company! |
|
|
|
Post by morfu on Jul 24, 2016 18:09:04 GMT -5
Nice video! However I have a quick question.. this video shows, how a long term sensor and an insulin pump can be used.. Assuming www.diabetes.co.uk/insulin/basal-bolus.html"A basal-bolus routine involves taking a longer acting form of insulin to keep blood glucose levels stable through periods of fasting and separate injections of shorter acting insulin to prevent rises in blood glucose levels resulting from meals." is true and Afrezza happens to be the best solution for the boreal insulin, the DexCom monitor does not change much for the boreal part, as it is mainly useful to detect/reduce basal problems, right!? |
|
|
|
Post by sportsrancho on Jul 24, 2016 19:15:22 GMT -5
Nice video! However I have a quick question.. this video shows, how a long term sensor and an insulin pump can be used.. Assuming www.diabetes.co.uk/insulin/basal-bolus.html"A basal-bolus routine involves taking a longer acting form of insulin to keep blood glucose levels stable through periods of fasting and separate injections of shorter acting insulin to prevent rises in blood glucose levels resulting from meals." is true and Afrezza happens to be the best solution for the boreal insulin, the DexCom monitor does not change much for the boreal part, as it is mainly useful to detect/reduce basal problems, right!? It's just amazing how much time it all takes. |
|
|
|
Post by agedhippie on Jul 24, 2016 22:14:28 GMT -5
Nice video! However I have a quick question.. this video shows, how a long term sensor and an insulin pump can be used.. Assuming www.diabetes.co.uk/insulin/basal-bolus.html"A basal-bolus routine involves taking a longer acting form of insulin to keep blood glucose levels stable through periods of fasting and separate injections of shorter acting insulin to prevent rises in blood glucose levels resulting from meals." [If this] is true and Afrezza happens to be the best solution for the bolus insulin, the DexCom monitor does not change much for the bolus part, as it is mainly useful to detect/reduce basal problems, right!? I changed your post to what I think you meant - apologies if I got it wrong. To answer the question the Dexcom is more useful to detect problems with the bolus insulin, basal is fairly constant so once you have it dialed in it only changes a couple of times a year or for illness. The most useful aspect is waking you up at night if you are dropping and the most annoy aspect is waking you up with a false alarm! If you lie on the sensor you can cut off it's signal or get a false low as well. |
|
|
|
Post by LosingMyBullishness on Jul 25, 2016 5:02:20 GMT -5
The approval was for the use of a G5 to dose insulin. There are already pumps that will suspend the basal if they thinks you are going low, but they were not allowed to dose if they thought you were going high. CGMs lag real time levels by around 20 minutes so to fix that they have predictive algorithms. These work out where you probably are from the historic data. It's why for the first couple of days they can be off while they settle down and why you have to do fingersticks every so often so they can check that their model has you at the same place that you actually are. There are various tricks you can do to make that all happen faster but you need other diabetics to tell you those because Dexcom won't. Last year Dexcom released their 505 firmware update and that finally got the accuracy to the same as a meter. The FDA approval now makes the G5 and meters equivalent and so permits dosing which clears the way for the artificial pancreas. The G4 uses the same firmware and sensors and has the same accuracy, but Dexcom only submitted the G5 for approval. There are pumps that already incorporate the G4 but the artificial pancreas devices will use the G5 as it has Bluetooth. I always dosed off a CGM when I am using one except when I feel it is wrong, then I use a meter to verify. Never knew "...so to fix that they have predictive algorithms." That's friggin' awesome. Thanks for dropping some knowledge. On a pissed off unrelated sidenote: 12 days until my 1-year anniversary bagholder status first started back in August 5th of 2015. Dear Pfeffer, Castagna & the BOD: sell the company IF it means Technosphere will survive and thrive later. Letting this technology disappear from modern medicine would be a damn shameful disgrace. Tron, You missed the opportunity to buy at around $10 per share. Now that is a reason to be pissed of. |
|
|
|
Post by LosingMyBullishness on Jul 25, 2016 5:03:27 GMT -5
Nice video! However I have a quick question.. this video shows, how a long term sensor and an insulin pump can be used.. Assuming www.diabetes.co.uk/insulin/basal-bolus.html"A basal-bolus routine involves taking a longer acting form of insulin to keep blood glucose levels stable through periods of fasting and separate injections of shorter acting insulin to prevent rises in blood glucose levels resulting from meals." is true and Afrezza happens to be the best solution for the boreal insulin, the DexCom monitor does not change much for the boreal part, as it is mainly useful to detect/reduce basal problems, right!? That clip is a bit too 'pink'. |
|
|
|
Post by peppy on Jul 25, 2016 5:38:10 GMT -5
A documentary as to how a diabetic becomes a clinician. They do know their equipment.
|
|
